FdaApplication
NDA 022200
Identifiers
- fda_app_no: NDA022200
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2012-01-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BYDUREON | EXENATIDE SYNTHETIC | 2MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| BYDUREON PEN | EXENATIDE SYNTHETIC | 2MG | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
2 products